In this multicentre , double-blind trial , between Oct 21 , 2013 , and Oct 30 , 2014 , we enrolled patients with HCV genotype 1 and compensated cirrhosis who had not achieved SVR after successive treatments with pegylated interferon and protease-inhibitor regimens at 20 sites in France .